This week's newsletter from Dermatology Times includes FDA approvals, melanoma drug delivery, cosmetic fillers, and more!
2-Year Study Affirms Bimekizumab's Efficacy in Hidradenitis Suppurativa
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
Interview Intersection: Expert Interviews From September 2024
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
The Weekly Roundup: September 23-27
Deuruxolitinib Shows Efficacy in Hair Regrowth, Patient Satisfaction, and Psychosocial Wellbeing in Severe Alopecia Areata